Literature DB >> 2439860

[Critical remarks on chemotherapy of malignant tumors of the head and neck].

U Ganzer, H Bier, C Bachert.   

Abstract

Chemotherapy of head and neck carcinomas has been the subject of 111 relevant publications reporting on more than 4,500 patients in the international literature of the past five years. Results of similar treatment protocols have been grouped together and tumour remission and survival time determined. Chemotherapy did not result in cure or increased survival times, neither alone nor in combination with irradiation nor when applied as adjuvant treatment. Inductive chemotherapy may result in producing a favourable effect on the prognosis of advanced carcinomas. The beneficial character of palliative chemotherapy is a generally accepted fact. Improvement of treatment results will be achieved only via centrally coordinated, randomised and prospective studies as well as by intensive fundamental research.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439860

Source DB:  PubMed          Journal:  Laryngol Rhinol Otol (Stuttg)        ISSN: 0340-1588


  3 in total

1.  Glutathione content and gamma-glutamyltranspeptidase activity in squamous cell head and neck cancer xenografts.

Authors:  H Bier; W Bergler; S Mende; U Ganzer
Journal:  Arch Otorhinolaryngol       Date:  1988

Review 2.  Chemotherapeutic drug resistance in the management of head and neck cancer.

Authors:  H Bier
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

3.  Systemic therapy strategies for head-neck carcinomas: Current status.

Authors:  Thomas K Hoffmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.